Tags
Celgene, a New Jersey biotechnology company, will pay $232 a share for Receptos, which is developing a drug for autoimmune diseases.
from NYT > Business Day http://ift.tt/1Hv5PZy
via IFTTThttp://ift.tt/1K5Sgpm http://ift.tt/IP98QF
Advertisements